Table 2.
Time in months until a.5% decline in gray matter density is detected in each region for the Alzheimer's disease subjects.
| Brain Region | All AD Subjects (months) |
|---|---|
| Hippo CA2 | 1.0 |
| Ch4 | 1.5 |
| Amygdala Astr | 1.5 |
| Amygdala SF | 1.5 |
| Auditory Te3 | 1.5 |
| Amygdala CM | 2.0 |
| Hippo EC | 2.0 |
| Hippo HATA | 2.0 |
| Ch123 | 2.5 |
| Hippo CA1 | 2.5 |
| Hippo CA3 | 2.5 |
| Broca BA44 | 2.5 |
| Broca BA45 | 2.5 |
| hOC2 | 2.5 |
| Auditory Te1 2 | 3.0 |
| Auditory Te1 0 | 3.5 |
| Amygdala LB | 4.0 |
| Auditory Te1 1 | 4.0 |
| hOC1 | 4.5 |
| PSC 1 | 5.0 |
| PSC 3a | 6.5 |
| Hippo Subc | 7.5 |
| PSC 2 | 10.0 |